An intronic alternative promoter of the human lactoferrin gene is activated by Ets

Biochemical and Biophysical Research Communications

Volumn 301, Issue 2, 2003, Pages 472-479

  Liu, Dianxin ^a   Wang, Xin ^a   Zhang, Zhiping ^a   Teng, Christina T ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Alternative promoter; Delta lactoferrin; Ets; GFP; Lactoferrin gene; Transfection

Indexed keywords

LACTOFERRIN; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW; CELL LINE; CELL NUCLEUS; CELL STRAIN U937; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; FLUORESCENCE ANALYSIS; GENE; GENE ACTIVATION; GENETIC REGULATION; GENETIC TRANSCRIPTION; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; LACTOFERRIN GENE; LEUKEMIA CELL LINE; MAMMARY GLAND; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; TUMOR CELL;

EID: 0037423761     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)03077-2     Document Type: Article

References (35)

1. Klintworth G.K., Sommer J.R., Obrian G., Han L., Ahmed M.N., Qumsiyeh M.B., Lin P.Y., Basti S., Reddy M.K., Kanai A., Hotta Y., Sugar J., Kumaramanickavel G., Munier F., Schorderet D.F., Matri L.E., Iwata F., Kaiser-Kupfer M., Nagata M., Nakayasu K., Hejtmancik J.F., Teng C.T. Familial subepithelial corneal amyloidosis (gelationous drop-like corneal dystrophy): exclusion of linkage to lactoferrin gene. Mol. Vis. 38:1997;31-38.
2. Park I., Schaeffer E., Sidoli A., Baralle F.E., Cohen G.N., Zakin M.M. Organization of the human transferrin gene: direct evidence that it originated by gene duplication. Proc. Natl. Acad. Sci. USA. 82:1985;3149-3153.
3. Pentecost B.T., Teng C.T. Lactotransferrin is the major estrogen inducible protein of mouse uterine secretions. J. Biol. Chem. 262:1987;10134-10139.
4. Brock J.H. The physiology of lactoferrin. Biochem. Cell Biol. 80:2002;1-6.
5. Baveye S., Elass E., Mazurier J., Spik G., Legrand D. Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process. Clin. Chem. Lab. Med. 37:1999;281-286.
6. Ward P.P., Uribe-Luna S., Conneely O.M. Lactoferrin and host defense. Biochem. Cell Biol. 80:2002;95-102.
7. Teng C.T. Lactoferrin gene expression and regulatoin: an overview. Biochem. Cell Biol. 80:2002;7-16.
8. Yang N., Shigeta H., Shi H., Teng C.T. Estrogen-related receptor, herr1, modulates estrogen receptor-mediated response of human lactoferrin gene promoter. J. Biol. Chem. 271:1996;5795-5804.
9. Morosetti R., Park D.J., Chumakov A.M., Grillier I., Shiohara M., Gombart A.F., Nakamaki T., Weinberg K., Koeffler H.P. A novel, myeloid transcription factor, C/EBP. ε, is upregulated during granulocytic, but not monocytic, differentiation Blood. 90:1997;2591-2600.
10. Verbeek W., Lekstrom-Himes J., Park D.J., Dang P.M.C., Vuong P.T., Kawano S., Babior B.M., Xanthopoulos K., Koeffler H.P. Myeloid transcription factor C/EBP. ε is involved in the positive regulation of lactoferrin gene expression in neutrophils Blood. 94:1999;3141-3150.
11. Khanna-Gupta A., Zibello T., Simkevich C., Rosmarin A.G., Berliner N. Sp1 and C/EBP are necessary to activate the lactoferrin gene promoter during myeloid differentiation. Blood. 95:2000;3734-3741.
12. KhannaGupta A., Zibello T., Kolla S., Neufeld E.J., Berliner N. Ccaat displacement protein (cdp/cut) recognizes a silencer element within the lactoferrin gene promoter. Blood. 90:1997;2784-2795.
13. Siebert P.D., Huang B.C.B. Identification of an alternative form of human lactoferrin mRNA that is expressed differentially in normal tissues and tumor-derived cell lines. Proc. Natl. Acad. Sci. USA. 94:1997;2198-2203.
14. Mann D.M., Romm E., Migliorini M. Delineation of the glycosaminoglycan-binding site in the human inflammatory response protein lactoferrin. J. Biol. Chem. 269:1994;23661-23667.
15. Nibbering P.H., Ravensbergen E., Welling M.M., van Berkel L.A., van Berkel P.H., Pauwels E.K., Nuijens J.H. Human lactoferrin and peptides derived from its n terminus are highly effective against infections with antibiotic-resistant bacteria. Infect. Immun. 69:2001;1469-1476.
16. Zhang G.H., Mann D.M., Tsai C.M. Neutralization of endotoxin in vitro and in vivo by a human lactoferrin-derived peptide. Infect. Immun. 67:1999;1353-1358.
17. Panella T.J., Liu Y.H., Huang A.T., Teng C.T. Polymorphism and altered methylation of the lactoferrin gene in normal leukocytes, leukemic-cells, and breast-cancer. Cancer Res. 51:1991;3037-3043.
18. Nye J.A., Petersen J.M., Gunther C.V., Jonsen M.D., Graves B.J. Interaction of murine Ets-1 with gga-binding sites establishes the Ets domain as a new DNA-binding motif. Genes Dev. 6:1992;975-990.
19. Wasylyk C., Kerckaert J.P., Wasylyk B. A novel modulator domain of Ets transcription factors. Genes Dev. 6:1992;965-974.
20. Teng C.T., Liu Y., Yang N., Walmer D., Panella T. Differential molecular mechanism of the estrogen action that regulates lactoferrin gene in human and mouse. Mol. Endocrinol. 6:1992;1969-1981.
21. Scohy S., Gabant P., Szpirer C., Szpirer J. Identification of an enhancer and an alternative promoter in the first intron of the. α -fetoprotein gene Nucleic Acids Res. 28:2000;3743-3751.
22. Goodwin L.O., Lees-Miller J.P., Leonard M.A., Cheley S.B., Helfman D.M. Four fibroblast tropomyosin isoforms are expressed from the rat. α -tropomyosin gene via alternative RNA splicing and the use of two promoters J. Biol. Chem. 266:1991;8408-8415.
23. Pischedda C., Cocco S., Melis A., Marini M.G., Kan Y.W., Cao A., Moi P. Isolation of a differentially regulated splicing isoform of human nf-e2. Proc. Natl. Acad. Sci. USA. 92:1995;3511-3515.
24. Moroni E., Mastrangelo T., Razzini R., Cairns L., Moi P., Ottolenghi S., Giglioni B. Regulation of mouse p45 nf-e2 transcription by an erythroid-specific gata-dependent intronic alternative promoter. J. Biol. Chem. 275:2000;10567-10576.
25. Aizencang G.I., Bishop D.F., Forrest D., Astrin K.H., Desnick R.J. Uroporphyrinogen III synthase. An alternative promoter controls erythroid-specific expression in the murine gene. J. Biol. Chem. 275:2000;2295-2304.
26. Sullivan P.M., Wang Y.M., Joseph D.R. Identification of an alternate promoter in the rat androgen-binding protein/sex hormone-binding globulin gene that regulates synthesis of a messenger RNA encoding a protein with altered function. Mol. Endocrinol. 7:1993;702-715.
27. Smale S.T., Baltimore D. The "initiator" as a transcription control element. Cell. 57:1989;103-113.
28. ′ -noncoding sequences from 699 vertebrate messenger RNAs Nucleic Acids Res. 15:1987;8125-8148.
29. Kozak M. At least six nucleotides preceding the aug initiator codon enhance translation in mammalian cells. J. Mol. Biol. 196:1987;947-950.
30. He J., Furmanski P. Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA. Nature. 373:1995;721-724.
31. Wasylyk B., Hahn S.L., Giovane A. The Ets family of transcription factors. Eur. J. Biochem. 211:1993;7-18.
32. Wasylyk C., Flores P., Gutman A., Wasylyk B. Pea3 is a nuclear target for transcription activation by non-nuclear oncogenes. EMBO J. 8:1989;3371-3378.
33. Chen J.H. The proto-oncogene c-Ets is preferentially expressed in lymphoid cells. Mol. Cell. Biol. 5:1985;2993-3000.
34. Woods D.B., Ghysdael J., Owen M.J. Identification of nucleotide preferences in DNA sequences recognised specifically by c-Ets-1 protein. Nucleic Acids Res. 20:1992;699-704.
35. Rosen G.D., Barks J.L., Iademarco M.F., Fisher R.J., Dean D.C. An intricate arrangement of binding sites for the Ets family of transcription factors regulates activity of the. α 4 integrin gene promoter J. Biol. Chem. 269:1994;15652-15660.